---------------------FOLLOW OUR NEW COMPANY PAGE - CATO SMS-----------------
Cato Research has merged with SMS-oncology forming CATO SMS, a fully integrated global company, delivering innovative strategies and robust solutions based on over 30 years of background in regulatory insight,
therapeutic experience, and operational expertise.
|
|
|
|
|
51-200 employees
View all Cato Research employees
|
|
|
Pharmaceuticals
|
|
|
919-361-2286
|
|
|
4364 South Alston Avenue, Durham, North Carolina 27713, US
|
|
|
1988
|
|
|
Program & Project Management, Pharmacokinetics, Clinical Trials, Quality Assurance, Manufacturing, Oncology, Regulatory Affairs, Chemistry, Regulatory Affairs, Cns, Oncology, Preclinical Services, Data Management & Biostatistics, & Controls, Preclinical Services, Clinical Strategy & Medical Writing, Medical & Pharmacovigilance, Cns, Rare Diseases & Orphan Drugs, Pharmacokinetics, Program & Project Management, Clinical Trials, Quality Assurance, Cell & Gene Therapy
|
Allen Cato is the CEO of Cato Research.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.